title: Primary cutaneous CD30+ lymphoproliferative disorder successfully treated by etretinate.
authors.forename: Satoshi
authors.initials: S
authors.lastname: Nakamura
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Hashimoto
authors.forename: Kaoru
authors.initials: K
authors.lastname: Nishi
authors.forename: Toshihiro
authors.initials: T
authors.lastname: Mizumoto
authors.forename: Hidetoshi
authors.initials: H
authors.lastname: Takahashi
authors.forename: Hajime
authors.initials: H
authors.lastname: Iizuka
mesh_terms: D003131:Combined Modality Therapy; D005050:Etretinate / Q000627:therapeutic use*; D006801:Humans; D007641:Keratolytic Agents / Q000627:therapeutic use*; D054446:Lymphoma, Primary Cutaneous Anaplastic Large Cell / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011701:PUVA Therapy; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D007641:Keratolytic Agents; D005050:Etretinate